BrainCool AB logo

BrainCool AB (BRAIN)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
0. 75
-0.01
-1.3158%
kr
415.05M Market Cap
- P/E Ratio
- Div Yield
64,243 Volume
- Eps
kr 0.76
Previous Close
Add Transaction
Day Range
0.73 0.76
Year Range
0.41 1.68
Want to track BRAIN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BRAIN closed today lower at kr0.75, a decrease of -1.3158% from yesterday's close, completing a monthly decrease of -5.7789% or -kr0.05. Over the past 12 months, BRAIN stock gained 31.3485%.
BRAIN is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0222%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

BRAIN Chart

People also search for

Pricer AB
kr -
-
BioArctic AB
kr -
-
DIAMYD MEDICAL AB
kr -
-
Bactiguard Holding AB
kr -
-
Genovis AB
kr 19.7
-0.5051%

BrainCool AB (BRAIN) FAQ

What is the stock price today?

The current price is kr0.75.

On which exchange is it traded?

BrainCool AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is BRAIN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 415.05M.

Has BrainCool AB ever had a stock split?

No, there has never been a stock split.

BrainCool AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Ms. Anna Lindstrom CEO
XSTO Exchange
SE0005731833 ISIN
DE Country
15 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

BrainCool AB (publ) is a pioneering medical device company operating out of Lund, Sweden. Founded in 2010, the company is dedicated to advancing the healthcare sector by focusing on the development, marketing, and sale of innovative medical cooling systems. BrainCool operates at both domestic and international levels, continuously working on enhancing its product lineup to cater to a wide array of medical situations requiring rapid cooling treatments. It addresses critical health issues such as stroke, sudden cardiac arrest, oral mucositis, and migraines. Through its commitment to improving patient care, BrainCool AB aims to position itself as a leader in the medical cooling treatment industry, providing solutions that facilitate a continuum of care from emergency settings to recovery and rehabilitation phases.

Products and Services

  • BrainCool System

    This system represents a cornerstone in BrainCool's product line, offering efficient and rapid cooling treatment options in emergency settings. It is specifically designed to ensure the continuum of care for patients suffering from conditions such as stroke or sudden cardiac arrest. The BrainCool System makes it easier for healthcare providers to initiate treatment promptly, potentially reducing the severity of these conditions.

  • RhinoChill System

    Targeted towards rapid medical cooling in both hospital and pre-hospital settings, the RhinoChill System is designed for versatility and ease of use. Its portability makes it ideally suited for use in ambulances or emergency care, where the immediate lowering of the patient's body temperature can be crucial for their recovery and survival.

  • Cooral System

    Understanding the significant impact of oral mucositis on patients undergoing certain cancer treatments, the Cooral System was developed to mitigate this challenging side effect. By providing a straightforward and effective cooling treatment directly to the oral cavity, the Cooral System aims to reduce the incidence and severity of oral mucositis, thereby improving the patient's quality of life during treatment.

  • IQool System

    With an emphasis on user-friendliness, the IQool System boasts an intuitive interface, enlightening graphics, and an automatic feedback loop. These features enable clinicians to focus more on patient care rather than equipment operation. The system is designed for managing therapeutic hypothermia, assisting in the regulation of the patient's body temperature with precision and ease.

Contact Information

Address: Medicon Village, Lund, Sweden, 223 81
Phone: 46 7 33 93 70 76